# Acasti Pharma Inc. (ACST)

Source: https://www.quantisnow.com/company/ACST
Generated: 2026-11-08T06:43:36.723Z

- Ticker: ACST
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- Website: acastipharma.com

## About

Acasti Pharma Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of prescription drugs for the treatment of cardiovascular diseases. Its lead product candidate is CaPre, an omega-3 phospholipid therapeutic that is in Phase III clinical trial to treat patients with hypertriglyceridemia; and TRILOGY that is in Phase III to evaluate the safety and efficacy of CaPre in patients with sHTG. The company was incorporated in 2002 and is headquartered in Laval, Canada.

## Latest ACST news and filings

- 2025-01-07 13:00 UTC [Conference Announcement] [Grace Therapeutics to Participate in Upcoming Investor Events January 2025](https://www.quantisnow.com/insight/grace-therapeutics-to-participate-in-upcoming-investor-events-january-2025-5836781)
- 2024-12-04 13:00 UTC [Conference Announcement] [Grace Therapeutics to Exhibit at the American Society of Health-System Pharmacists Conference](https://www.quantisnow.com/insight/grace-therapeutics-to-exhibit-at-the-american-society-of-health-system-5799499)
- 2024-10-28 12:22 UTC [SEC Form 8-K] [Acasti Pharma Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits](https://www.quantisnow.com/insight/acasti-pharma-inc-filed-sec-form-8-k-amendments-to-articles-5739457)
- 2024-10-25 12:13 UTC [SEC Form 8-K] [Acasti Pharma Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/acasti-pharma-inc-filed-sec-form-8-k-other-events-financial-5738127)
- 2024-10-25 12:00 UTC [Acasti Announces Corporate Name Change  to Grace Therapeutics, Inc.](https://www.quantisnow.com/insight/acasti-announces-corporate-name-change-to-grace-therapeutics-inc-5738076)
- 2024-10-16 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Acasti Pharma Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-acasti-pharma-inc-5726429)
- 2024-10-16 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Acasti Pharma Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-acasti-pharma-inc-5726420)
- 2024-10-08 11:22 UTC [SEC Form S-8] [SEC Form S-8 filed by Acasti Pharma Inc.](https://www.quantisnow.com/insight/sec-form-s-8-filed-by-acasti-pharma-inc-5719033)
- 2024-10-08 11:16 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Acasti Pharma Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-acasti-pharma-inc-5719027)
- 2024-10-08 11:16 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Acasti Pharma Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-acasti-pharma-inc-5719026)
- 2024-10-08 11:16 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Acasti Pharma Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-acasti-pharma-inc-5719023)
- 2024-10-08 11:15 UTC [SEC Form POS AM filed by Acasti Pharma Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-acasti-pharma-inc-5719021)
- 2024-10-08 11:13 UTC [SEC Form POS AM filed by Acasti Pharma Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-acasti-pharma-inc-5719013)
- 2024-09-30 20:31 UTC [SEC Form 8-K] [Acasti Pharma Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits](https://www.quantisnow.com/insight/acasti-pharma-inc-filed-sec-form-8-k-leadership-update-submission-5708663)
- 2024-09-25 12:00 UTC [SEC Form 8-K] [Acasti Pharma Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/acasti-pharma-inc-filed-sec-form-8-k-other-events-financial-5704163)
- 2024-09-25 11:30 UTC [Acasti Announces Completion of Patient Enrollment in Pivotal Phase 3 STRIVE-ON Safety Trial of GTX-104](https://www.quantisnow.com/insight/acasti-announces-completion-of-patient-enrollment-in-pivotal-phase-3-5704111)
- 2024-09-12 12:00 UTC [Conference Announcement] [Acasti to Present at the Life Sciences Investor Forum](https://www.quantisnow.com/insight/acasti-to-present-at-the-life-sciences-investor-forum-5691397)
- 2024-09-06 20:07 UTC [SEC Form DEFA14A] [SEC Form DEFA14A filed by Acasti Pharma Inc.](https://www.quantisnow.com/insight/sec-form-defa14a-filed-by-acasti-pharma-inc-5685800)
- 2024-09-05 14:35 UTC [Conference Announcement] [Acasti to Participate in the H.C. Wainwright 26th Annual Global Investment Conference](https://www.quantisnow.com/insight/acasti-to-participate-in-the-hc-wainwright-26th-annual-global-5683836)
- 2024-08-16 20:05 UTC [SEC Form 8-K] [Acasti Pharma Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits](https://www.quantisnow.com/insight/acasti-pharma-inc-filed-sec-form-8-k-leadership-update-financial-5662716)
- 2024-08-09 12:00 UTC [SEC Form 8-K] [Acasti Pharma Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/acasti-pharma-inc-filed-sec-form-8-k-results-of-operations-5652145)
- 2024-08-09 12:00 UTC [Acasti Announces First Fiscal Quarter 2025 Financial Results, Provides Business Update](https://www.quantisnow.com/insight/acasti-announces-first-fiscal-quarter-2025-financial-results-provides-business-5652118)
- 2024-08-09 11:30 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Acasti Pharma Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-acasti-pharma-inc-5652069)
- 2024-08-07 20:14 UTC [SEC Form 424B3] [SEC Form 424B3 filed by Acasti Pharma Inc.](https://www.quantisnow.com/insight/sec-form-424b3-filed-by-acasti-pharma-inc-5647714)
- 2024-08-05 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Acasti Pharma Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-acasti-pharma-inc-5641191)
- 2024-07-31 11:22 UTC [SEC Form S-4] [Amendment: SEC Form S-4/A filed by Acasti Pharma Inc.](https://www.quantisnow.com/insight/amendment-sec-form-s-4a-filed-by-acasti-pharma-inc-5634503)
- 2024-07-11 15:16 UTC [SEC Form 3] [Amendment: New insider Adar1 Capital Management, Llc claimed ownership of 959,571 shares (SEC Form 3)](https://www.quantisnow.com/insight/amendment-new-insider-adar1-capital-management-llc-claimed-ownership-of-5603911)
- 2024-07-11 01:10 UTC [SEC Schedule 13G] [SEC Form SC 13G filed by Acasti Pharma Inc.](https://www.quantisnow.com/insight/sec-form-sc-13g-filed-by-acasti-pharma-inc-5602828)
- 2024-07-10 00:29 UTC [SEC Form 3] [New insider Adar1 Capital Management, Llc claimed ownership of 959,571 shares (SEC Form 3)](https://www.quantisnow.com/insight/new-insider-adar1-capital-management-llc-claimed-ownership-of-959571-5600511)
- 2024-06-27 21:01 UTC [SEC Form S-4] [SEC Form S-4 filed by Acasti Pharma Inc.](https://www.quantisnow.com/insight/sec-form-s-4-filed-by-acasti-pharma-inc-5581841)
- 2024-06-27 20:10 UTC [SEC Form 8-K] [Acasti Pharma Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/acasti-pharma-inc-filed-sec-form-8-k-other-events-financial-5581415)
- 2024-06-27 20:06 UTC [Market Chatter] [Acasti Reaches 50% Enrollment In Pivotal Phase 3 STRIVE-ON Safety Trial](https://www.quantisnow.com/insight/acasti-reaches-50-enrollment-in-pivotal-phase-3-strive-on-safety-5581368)
- 2024-06-27 20:05 UTC [Acasti Announces Achievement of 50% Enrollment in Pivotal Phase 3 STRIVE-ON Safety Trial](https://www.quantisnow.com/insight/acasti-announces-achievement-of-50-enrollment-in-pivotal-phase-3-5581304)
- 2024-06-21 12:09 UTC [Market Chatter] [Acasti Pharma FY24 Revenue $(1.35) Up From $(5.71) YoY](https://www.quantisnow.com/insight/acasti-pharma-fy24-revenue-135-up-from-571-yoy-5570084)
- 2024-06-21 12:00 UTC [SEC Form 8-K] [Acasti Pharma Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/acasti-pharma-inc-filed-sec-form-8-k-results-of-operations-5570049)
- 2024-06-21 12:00 UTC [Acasti Announces Year-End 2024 Financial Results, Provides Business Update](https://www.quantisnow.com/insight/acasti-announces-year-end-2024-financial-results-provides-business-update-5570024)
- 2024-06-21 11:30 UTC [SEC Form 10-K] [SEC Form 10-K filed by Acasti Pharma Inc.](https://www.quantisnow.com/insight/sec-form-10-k-filed-by-acasti-pharma-inc-5569989)
- 2024-05-28 20:05 UTC [Acasti Pharma to Attend BIO International Convention 2024](https://www.quantisnow.com/insight/acasti-pharma-to-attend-bio-international-convention-2024-5519886)
- 2024-05-10 20:11 UTC [SEC Form 4] [SEC Form 4 filed by D'Andrea Carrie (Amendment)](https://www.quantisnow.com/insight/sec-form-4-filed-by-dandrea-carrie-amendment-5481862)
- 2024-05-10 20:07 UTC [SEC Form 4] [SEC Form 4 filed by Kumar Amresh (Amendment)](https://www.quantisnow.com/insight/sec-form-4-filed-by-kumar-amresh-amendment-5481789)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/ACST
- Earnings history: https://www.quantisnow.com/earnings/ACST
- Dividend history: https://www.quantisnow.com/dividends/ACST
- Insider transactions: https://www.quantisnow.com/insiders/ACST
- Options chain: https://www.quantisnow.com/options/ACST
- SEC 8-K filings only: https://www.quantisnow.com/company/ACST/8-k
- RSS and alerts for ACST: https://www.quantisnow.com/docs/rss-feeds.md